Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Prepaid Assets: 2011-2025

Historic Prepaid Assets for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $2.2 million.

  • Abeona Therapeutics' Prepaid Assets rose 119.80% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 119.80%. This contributed to the annual value of $1.1 million for FY2024, which is 56.79% up from last year.
  • Per Abeona Therapeutics' latest filing, its Prepaid Assets stood at $2.2 million for Q3 2025, which was up 5.69% from $2.1 million recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Prepaid Assets high stood at $2.4 million for Q4 2021, and its period low was $424,000 during Q4 2022.
  • Over the past 3 years, Abeona Therapeutics' median Prepaid Assets value was $1.2 million (recorded in 2024), while the average stood at $1.5 million.
  • Per our database at Business Quant, Abeona Therapeutics' Prepaid Assets slumped by 82.16% in 2022 and then skyrocketed by 119.80% in 2025.
  • Abeona Therapeutics' Prepaid Assets (Quarterly) stood at $2.4 million in 2021, then plummeted by 82.16% to $424,000 in 2022, then soared by 71.93% to $729,000 in 2023, then skyrocketed by 56.79% to $1.1 million in 2024, then soared by 119.80% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.1 million for Q2 2025, and $2.0 million during Q1 2025.